Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hermanns

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Urologic Oncology|August 8, 2017
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicionBimal Bhindi, Haiyan Jiang, Cedric Poyet, et al.
Scientific Reports|March 4, 2020
Basic Hallmarks of Urothelial Cancer Unleashed in Primary Uroepithelium by Interference with the Epigenetic Master Regulator ODC1Lars Erichsen, Hans-Helge Seifert, Wolfgang A Schulz, et al.
British Journal of Cancer|December 15, 2015
Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomyBimal Bhindi, Thomas Hermanns, Yanliang Wei, et al.
Plos One|July 15, 2011
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerLotta von Boehmer, Lukas Keller, Ashkan Mortezavi, et al.
Frontiers in Oncology|December 26, 2022
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrenceAilsa J Christiansen, João Lobo, Christian D Fankhauser, et al.
Plos One|April 22, 2017
Risk stratification for venous thromboembolism in patients with testicular germ cell tumorsAngelika Bezan, Florian Posch, Ferdinand Ploner, et al.
British Journal of Cancer|December 16, 2021
Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumoursChristian D Fankhauser, Ailsa J Christiansen, Christian Rothermundt, et al.
Cell Reports. Medicine|May 2, 2022
Single-cell proteomics defines the cellular heterogeneity of localized prostate cancerLaura De Vargas Roditi, Andrea Jacobs, Jan H Rueschoff, et al.
Neoplasia (New York, N.Y.)|November 4, 2024
Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer centerJens von der Grün, Maiwand Ahmadsei, Isabel Breyer, et al.
Aktuelle Urologie|November 21, 2019
[Knowledge of German-speaking urologists regarding the association between penile cancer and human papilloma virus: results of a survey of the European PROspective Penile Cancer Study (E-PROPS)]Steffen Lebentrau, Ingmar Wolff, Marie Christine Hempel, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Urologic Oncology|August 8, 2017
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicionBimal Bhindi, Haiyan Jiang, Cedric Poyet, et al.
Scientific Reports|March 4, 2020
Basic Hallmarks of Urothelial Cancer Unleashed in Primary Uroepithelium by Interference with the Epigenetic Master Regulator ODC1Lars Erichsen, Hans-Helge Seifert, Wolfgang A Schulz, et al.
British Journal of Cancer|December 15, 2015
Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomyBimal Bhindi, Thomas Hermanns, Yanliang Wei, et al.
Plos One|July 15, 2011
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerLotta von Boehmer, Lukas Keller, Ashkan Mortezavi, et al.
Frontiers in Oncology|December 26, 2022
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrenceAilsa J Christiansen, João Lobo, Christian D Fankhauser, et al.
Plos One|April 22, 2017
Risk stratification for venous thromboembolism in patients with testicular germ cell tumorsAngelika Bezan, Florian Posch, Ferdinand Ploner, et al.
British Journal of Cancer|December 16, 2021
Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumoursChristian D Fankhauser, Ailsa J Christiansen, Christian Rothermundt, et al.
Cell Reports. Medicine|May 2, 2022
Single-cell proteomics defines the cellular heterogeneity of localized prostate cancerLaura De Vargas Roditi, Andrea Jacobs, Jan H Rueschoff, et al.
Neoplasia (New York, N.Y.)|November 4, 2024
Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer centerJens von der Grün, Maiwand Ahmadsei, Isabel Breyer, et al.
Aktuelle Urologie|November 21, 2019
[Knowledge of German-speaking urologists regarding the association between penile cancer and human papilloma virus: results of a survey of the European PROspective Penile Cancer Study (E-PROPS)]Steffen Lebentrau, Ingmar Wolff, Marie Christine Hempel, et al.
Pageof 19